Avecia
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies. In 2016, Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. Avecia was organized with a biologics business line and the oligonucleotide business line.
Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies. In 2016, Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. Avecia was organized with a biologics business line and the oligonucleotide business line.
References
External links
Avecia.com
Text derived from https://en.wikipedia.org/w/index.php?oldid=1344147331 under CC BY-SA 4.0; modifications have been made.